BMPR2 and heritable pulmonary arterial hypertension: For example, bone morphogenetic protein receptor type 2 (BMPR2) mutations are observed in 60–80% of familial (FPAH) cases, but data from population registries indicate that penetrance of the disease phenotype ranges from 14 to 42% [6].